Skip to main content
Log in

Early markers of cognitive enhancement: developing an implicit measure of cognitive performance

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

There is intense interest in the development of effective cognitive enhancing drugs which would have therapeutic application across a number of neurological and psychological disorders including dementia, schizophrenia and depression. However, development in this area has been limited by the absence of sensitive biomarkers which can be used to detect and refine therapeutic-like action in phase 1 clinical studies. The aim of the present study was therefore to develop a measure of cognition relevant to the action of candidate cognitive enhancers which might be sensitive to pharmacological manipulation in healthy volunteers. Healthy volunteers (n = 34) were randomised to receive a single dose of modafinil (100 mg) or placebo. Five hours post dose, attentional flexibility in learning was assessed using a novel implicit learning task. Volunteers also completed an auditory digit span task and visual analogue scales (VAS). Modafinil increased alertness as measured by the VAS. In the implicit learning task, modafinil enhanced learning rates in terms of both accuracy and reaction time, suggesting an increase in implicit rule learning. These results suggest that the novel learning task should be explored as a biomarker of early cognitive improvement which could be more sensitive than conventional measures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Baranski JV, Pigeau R, Dinich P, Jacobs I (2004) Effects of modafinil on cognitive and meta-cognitive performance. Human Psychopharmacology 19:323–332

    Article  PubMed  CAS  Google Scholar 

  • Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD (2010) Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34:1161–1177

    Article  PubMed  Google Scholar 

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571

    Article  PubMed  CAS  Google Scholar 

  • Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218

    Article  Google Scholar 

  • Cleeremans A (2006) Conscious and unconscious cognition: a graded dynamic perspective. Psychology Press, Hove

    Google Scholar 

  • Eysenck SBG, Eysenck HJ, Barrett P (1985) A revised version of the psychoticism scale. Personal Individ Differ 6:21–29

    Article  Google Scholar 

  • First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for axis I and II DSM-IV disorders: patient edition (SCID-IV/P). Biometrics Research Department, New York

    Google Scholar 

  • Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, Lopez-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW (2009) Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res 115:104–114

    Article  PubMed  Google Scholar 

  • Harmer C, Cowen P, Goodwin G (2011) Efficacy markers in depression. J Psychopharmacol (Oxford, England) 25:1148–1158

    Article  CAS  Google Scholar 

  • Hunter MD, Ganesan V, Wilkinson ID, Spence SA (2006) Impact of modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry 163:2184–2186

    Article  PubMed  Google Scholar 

  • Husain M, Mehta MA (2011) Cognitive enhancement by drugs in health and disease. Trends Cogn Sci 15:28–36

    Article  PubMed  CAS  Google Scholar 

  • Kaufman SB, Deyoung CG, Gray JR, Jimenez L, Brown J, Mackintosh N (2010) Implicit learning as an ability. Cognition 116:321–340

    Article  PubMed  Google Scholar 

  • Loose R, Kaufmann C, Tucha O, Auer DP, Lange KW (2006) Neural networks of response shifting: influence of task speed and stimulus material. Brain Res 1090:146–155

    Article  PubMed  CAS  Google Scholar 

  • MacLeod CM, Mathews A, Tata P (1986) Attentional bias in emotional disorders. J Abnorm Psychol 95:15–20

    Article  PubMed  CAS  Google Scholar 

  • Marchant NL, Kamel F, Echlin K, Grice J, Lewis M, Rusted JM (2009) Modafinil improves rapid shifts of attention. Psychopharmacology (Berl) 202:487–495

    Article  CAS  Google Scholar 

  • Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65

    PubMed  CAS  Google Scholar 

  • Millan MJ, Agid Y, Brune M, Bullmore ET, Carter CS, Clayton NS, Connor R, Davis S, Deakin B, DeRubeis RJ, Dubois B, Geyer MA, Goodwin GM, Gorwood P, Jay TM, Joels M, Mansuy IM, Meyer-Lindenberg A, Murphy D, Rolls E, Saletu B, Spedding M, Sweeney J, Whittington M, Young LJ (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141–168

    Article  PubMed  CAS  Google Scholar 

  • Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33:1477–1502

    Article  PubMed  CAS  Google Scholar 

  • Muller U, Rowe JB, Rittman T, Lewis C, Robbins TW, Sahakian BJ (2013) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64:490–495

    Article  PubMed  CAS  Google Scholar 

  • Murphy SE, Longhitano CL, Ayres RE, Cowen PJ, Harmer CJ (2006) Tryptophan supplementation induces a positive bias in the processing of emotional material in healthy female volunteers. Psychopharmacology 187:121–130

    Article  PubMed  CAS  Google Scholar 

  • Nelson HE (1982) National Adult Reading Test (NART): test manual. NFER-Nelson, Windsor

    Google Scholar 

  • Nosek BA, Hawkins CB, Frazier RS (2011) Implicit social cognition: from measures to mechanisms. Trends Cogn Sci 15:152–159

    Article  PubMed  Google Scholar 

  • Randall DC, Shneerson JM, Plaha KK, File SE (2003) Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 18:163–173

    Article  PubMed  CAS  Google Scholar 

  • Randall DC, Fleck NL, Shneerson JM, File SE (2004) The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers. Pharmacol Biochem Behav 77:547–555

    Article  PubMed  CAS  Google Scholar 

  • Randall DC, Shneerson JM, File SE (2005a) Cognitive effects of modafinil in student volunteers may depend on IQ. Pharmacol Biochem Behav 82:133–139

    Article  PubMed  CAS  Google Scholar 

  • Randall DC, Viswanath A, Bharania P, Elsabagh SM, Hartley DE, Shneerson JM, File SE (2005b) Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived? J Clin Psychopharmacol 25:175–179

    Article  PubMed  CAS  Google Scholar 

  • Rasetti R, Mattay VS, Stankevich B, Skjei K, Blasi G, Sambataro F, Arrillaga-Romany IC, Goldberg TE, Callicot JH, Apud JA, Weinberger DR (2010) Modulatory effects of modafinil on neural circuits regulating emotion and cognition. Neuropsychopharmacology 35:2101–2109

    Article  PubMed  CAS  Google Scholar 

  • Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267–287

    Article  PubMed  CAS  Google Scholar 

  • Spielberger CD, Gorsuch RL, Lushene RD (1970) STAI manual. Consulting Psychologists Press, Palo Alto

    Google Scholar 

  • Stacy AW, Wiers RW (2010) Implicit cognition and addiction: a tool for explaining paradoxical behavior. Annu Rev Clin Psychol 6:551–575

    Article  PubMed  Google Scholar 

  • Sylvester CY, Wager TD, Lacey SC, Hernandez L, Nichols TE, Smith EE, Jonides J (2003) Switching attention and resolving interference: fMRI measures of executive functions. Neuropsychologia 41:357–370

    Article  PubMed  Google Scholar 

  • Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ (2003) Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 165:260–269

    CAS  Google Scholar 

  • Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ (2004a) Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 55:1031–1040

    Article  PubMed  CAS  Google Scholar 

  • Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ (2004b) Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29:1363–1373

    Article  PubMed  CAS  Google Scholar 

  • von Zerseen D, Strian F, Schwarz D (1974) Evaluation of depressive states, especially in longitudinal studies. In: Pichot B (ed) Psychological measurements in psychopharmacology. Karger, Basel

    Google Scholar 

  • Watson D, Clarke LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the positive and negative affect schedule scales. J Personal Soc Psychol 54:1063–1070

    Article  CAS  Google Scholar 

  • Wiers RW, Teachman BA, De Houwer J (2007) Implicit cognitive processes in psychopathology: an introduction. J Behav Ther Exp Psychiatry 38:95–104

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

CJH has acted as a consultant for the following companies: Servier, GSK, Astra-Zeneca. Lundbeck and P1vital. She also holds shares in P1vital and is on the advisory board. PJC has been a paid member of advisory boards of Eli Lilly, Lundbeck, Servier and Wyeth and has been a paid lecturer for Eli Lilly, Lundbeck, GlaxoSmithKline and Servier. He has received remuneration for scientific advice given to legal representatives of GlaxoSmithKline. AP, EP and MB report no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abbie Pringle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pringle, A., Browning, M., Parsons, E. et al. Early markers of cognitive enhancement: developing an implicit measure of cognitive performance. Psychopharmacology 230, 631–638 (2013). https://doi.org/10.1007/s00213-013-3186-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-013-3186-6

Keywords

Navigation